Class IIITerminated in FDA datasetRecall initiated Jun 11, 2012

Product Name: Eroxil bottles of 30 tablets taken orally Nokomis Research Inc #6

Recalling firm: H & L Jerch Sales, Inc.

Why it was recalled

The products contain synthetic equivalents of spermine and/or spermidine, which are constituents or extracts of an herb or other botanical, and the that a synthetic copy of a…

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Feb 12, 2013.

Check your package

Compare the exact product and package details with the label you have.

ProductProduct Name: Eroxil bottles of 30 tablets taken orally Nokomis Research Inc #6
UPC771733109000

FDA code information

Catalog number: #6: UPC 771733109000; and lot numbers: 11154, 11185, 11186, 11267, 11269, 12014, 12057, 12099, 12220, and 12244.

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Product Name: Eroxil bottles of 30 tablets taken orally Nokomis Research Inc #6

Extracted codes and context

TypeCode / valueContext
UPC771733109000Catalog number: #6: UPC 771733109000; and lot numbers: 11154, 11185, 11186, 11267, 11269, 12014, 12057, 12099, 12220, and 12244.

Original FDA recall reason

The products contain synthetic equivalents of spermine and/or spermidine, which are constituents or extracts of an herb or other botanical, and the that a synthetic copy of a constituent or extract of an herb or other botanical is not a dietary ingredient, and such ingredients must be approved for use in supplements. The use has not been approved.

Recall details

Recall number
F-1729-2012
Event ID
61842
FDA status
Terminated
Initiated
Jun 11, 2012
Reported
Jul 18, 2012
Classified
Jul 6, 2012
Terminated
Feb 12, 2013
Quantity
50,604 bottles
Location
South Haven, MI, United States
Initiation type
Voluntary: Firm initiated
Notification
Letter

Where it was distributed

Nationwide

FDA source record · F-1729-2012

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.